A WORRYING amount of Brits are developing mouth cancer, with a new report warning of record-breaking cases. Some 10,825 ...

PDS Biotechnology shares declined after it issued an update about a cancer study with a combination of Versamune HPV and pembrolizumab and reported quarterly results. The stock was down 18%, to $2.25, ...

A recent health awareness program at MD Public School in Varanasi, organized by IMS BHU and Mamta Health Institute, educates adolescent girls on menstrual hygiene, balanced nutrition, and the ...

It's long been known HPV can impact women's fertility, but a new study suggests it could be causing some men's struggles too.

Researchers stressed that HPV is one of the biggest risk factors for mouth cancer. According to Cancer Research UK, 70 per ...

In October 2024, we provided updated results from our IMMUNOCERV Phase 2 clinical trial in locally advanced cervical cancer patients treated with Versamune ® HPV and chemoradiotherapy presented at the ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

As Louisiana’s rate of fully vaccinated children slips as part of blowback related to the COVID-19 pandemic, health care ...

Vaxart Inc (VXRT) reports significant progress in its COVID-19 and Norovirus programs, backed by strong governmental support ...

India faces a growing cancer crisis fueled by lifestyle choices and environmental factors. Preventing cancer may feel like a ...

Kronos is considering whether to partner its two preclinical lysine acetyltransferase (KAT) inhibitor programs, which include ...

I'll then have James and Sean share updates on our COVID, Norovirus and HPV programs respectively. Then Phil will discuss our financial results before we open the call for your questions. When I ...